GlassScriptPhysician profile
Esther M Moon
NPI 1649230186
$1,616.79
in general payments reported to CMS, 2019-2025
22 companies · $537 in 2025
The $537 reported for 2025 was more than what 82% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $345 · 2020: $130 · 2022: $125 · 2023: $189 · 2024: $289 · 2025: $537.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $931 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $931.34 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $234.66 | 2020-2025 | Veozah, Myrbetriq |
| Novo Nordisk INC | $201.91 | 2020-2025 | Wegovy |
| Exeltis, USA INC. | $173.23 | 2022-2025 | Slynd |
| Abbvie INC. | $159.78 | 2019 | |
| Pfizer INC. | $155.77 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $111.69 | 2023-2025 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $110.03 | 2019-2025 | |
| Biogen, INC. | $89.18 | 2025 | Zurzuvae |
| Intuitive Surgical, INC. | $65.31 | 2020 | |
| Myovant Sciences INC. | $46.11 | 2022 | |
| Shield Therapeutics INC | $38.54 | 2025 | |
| Amgen INC. | $33.35 | 2019-2022 | |
| Lupin INC. | $29.24 | 2019-2020 | |
| Coopersurgical, INC. | $26.82 | 2019 | |
| Avion Pharmaceuticals | $25.97 | 2019-2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $23.50 | 2022 | |
| Therapeuticsmd, INC. | $19.28 | 2022 | |
| Millicent US INC | $17.61 | 2025 | Femlyv |
| Amag Pharmaceuticals, INC. | $15.54 | 2019 | |
| Covidien LP | $15.10 | 2019 | |
| Merck Sharp & Dohme LLC | $15.01 | 2019 | |
| Meditrina | $9.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Esther Moon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.